Tatsumori Yoshida
Président chez C&O Pharmaceutical Technology (Holdings) Ltd.
Postes actifs de Tatsumori Yoshida
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
 C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Président | 16/04/2018 | - |
Historique de carrière de Tatsumori Yoshida
Formation de Tatsumori Yoshida
| Osaka Prefecture University | Undergraduate Degree |
Statistiques
Internationale
| Japon | 2 |
| Hong Kong | 2 |
Opérationnelle
| Undergraduate Degree | 1 |
| Chairman | 1 |
Sectorielle
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Health Technology |
- Bourse
- Insiders
- Tatsumori Yoshida
- Expérience
